Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy Article

cited authors

  • Weiss, Jared M.; Pennell, Nathan; Deal, Allison M.; Morgenzstern, Daniel; Bradford, Daniel S.; Crane, Jeffrey; West, Howard Jack; Lee, Carrie; Pecot, Chad; Stevenson, James P.; Irvin, William; Socinski, Mark; Stinchcombe, Tom; Villaruz, Liza C.; Muss, Hyman B.

authors

Publication Date

  • January 14, 2020

webpage

published in

category

keywords

  • elderly
  • geriatric assessment
  • lymphocyte p16
  • nanoparticle albumin-bound (nab)-paclitaxel
  • non-small cell lung cancer (NSCLC)
  • sarcopenia

start page

  • 1060

end page

  • 1067

volume

  • 126

issue

  • 5